Adjunctive Treatment With Eslicarbazepine Acetate for Adults and Children With Focal-Onset Epilepsy: A Meta-Analysis

Adjunctive Treatment With Eslicarbazepine Acetate for Adults and Children With Focal-Onset Epilepsy: A Meta-Analysis

BackgroundThe efficacy and tolerability of eslicarbazepine acetate (ESL) in adults and children with focal-onset epilepsy (FOE) according to the dose remain to be validated. A meta-analysis based on randomized controlled trials (RCTs) was therefore conducted as a summary.MethodsRelevant RCTs were co...

Full description

Bibliographic Details
Main Authors:	Yanqing Fei, Ruting Shi, Zhi Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Neurology
Subjects:	eslicarbazepine acetate focal-onset epilepsy adjunctive treatment randomized controlled trials meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.909471/full

Similar Items

Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies
by: Martyna Stefaniak, et al.
Published: (2022-02-01)

Psychiatric adverse events in three phase III trials of eslicarbazepine acetate for focal seizures
by: Hamada Altalib, et al.
Published: (2022-12-01)

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
by: Charlotte Lawthom, et al.
Published: (2019-05-01)

Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
by: Charlotte Lawthom, et al.
Published: (2018-09-01)

Eslicarbazepine acetate: A therapeutic agent of paramount importance in acute anticonvulsant therapy
by: Farah Iram, et al.
Published: (2017-01-01)

Efficacy and safety of using eslicarbazepine in treating focal epilepsy in clinical practice (based on international Euro-Esli study and personal experience)
by: I. A. Zhidkova, et al.
Published: (2020-11-01)

Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses
by: Darshan Mehta, et al.
Published: (2020-09-01)

Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice
by: Mehta D, et al.
Published: (2020-07-01)

Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs
by: Mehta D, et al.
Published: (2021-04-01)

Inhibitory Effect of Eslicarbazepine Acetate and S-Licarbazepine on Nav1.5 Channels
by: Theresa K. Leslie, et al.
Published: (2020-10-01)

Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias
by: Christopher D. Ma, et al.
Published: (2022-09-01)

An overview of the construction of emergency and pre-hospital first aid platform
by: Song Chen, et al.
Published: (2018-01-01)

Identification of metabolic pathways involved in the biotransformation of eslicarbazepine acetate using UPLC-MS/MS, human microsomal enzymes and in silico studies
by: Asif Husain, et al.
Published: (2021-03-01)

Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses
by: Doğan EA, et al.
Published: (2018-08-01)

Emergency treatment of proximal femural fracture within 48h: The Umbria Region experience
by: Pellegrino Ferrara, et al.
Published: (2017-01-01)

Evaluation of the Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Perampanel in Rats by Isotope-Dilution-UHPLC-MS/MS
by: Liu P, et al.
Published: (2022-11-01)

Eslicarbazepine‐induced hyponatremia: A retrospective single‐center real clinical practice study
by: Ondřej Strýček, et al.
Published: (2024-02-01)

Long‐term efficacy and safety of adjunctive perampanel in patients from the Asia‐Pacific region with refractory focal‐onset seizures in Study 335 open‐label extension
by: Takuji Nishida, et al.
Published: (2024-04-01)

Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling
by: Cecilia Zavala-Tecuapetla, et al.
Published: (2022-05-01)

Genetic generalized epilepsy and generalized onset seizures with focal evolution (GOFE)
by: Florian Lamy, et al.
Published: (2022-01-01)

Comparative antiseizure medications of adjunctive treatment for children with drug-resistant focal-onset seizures: A systematic review and network meta-analysis
by: Lanlan Zhang, et al.
Published: (2022-12-01)

New developments in the management of partial-onset epilepsy: role of brivaracetam
by: Coppola G, et al.
Published: (2017-03-01)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
by: Yiming Li, et al.
Published: (2022-06-01)

Correspondence between scalp‐EEG and stereoelectroencephalography seizure‐onset patterns in patients with MRI‐negative drug‐resistant focal epilepsy
by: Anna Bolzan, et al.
Published: (2024-04-01)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
by: Chunsong Yang, et al.
Published: (2023-08-01)

The Role of Add-On Lacosamide Therapy in the Treatment of Focal Onset Epilepsy
by: Güray KOÇ, et al.
Published: (2017-12-01)

A Review of Eslicarbazepine Acetate for the Adjunctive Treatment of Partial-Onset Epilepsy
by: Rajinder P. Singh, et al.
Published: (2011-01-01)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
by: Gao L, et al.
Published: (2016-05-01)

Neuroimaging in Focal Epilepsies: An Update
by: Vanessa C Mendes COELHO, et al.
Published: (2015-12-01)

New evidence in adjunctive treatment of focal-onset seizures in adults: a critical appraisal
by: Simona Alfiere Lattanzi
Published: (2022-06-01)

An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients
by: Dozières-Puyravel B, et al.
Published: (2019-09-01)

Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01)

Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
by: Janković SM, et al.
Published: (2021-03-01)

Late onset psychosis treatment with adjunctive medicines
by: Irina Boksha, et al.
Published: (2023-12-01)

The bidirectional relationship between Alzheimer's disease (AD) and epilepsy: A Mendelian randomization study
by: Lianping Xu, et al.
Published: (2023-11-01)

LEVETINOL IN COMPLEX TREATMENT OF FOCAL EPILEPSY (EXPERIENCE OF EPILEPTOLOGIST IN OUTPATIENT NETWORK, MOSCOW)
by: G. G. Avakyan, et al.
Published: (2016-05-01)

Changes and significance of gut microbiota in children with focal epilepsy before and after treatment
by: Changci Zhou, et al.
Published: (2022-11-01)

Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study
by: Mustafa Karaoğlan
Published: (2018-06-01)

The Effect of Lacosamide Polytherapy on Seizure Prognosis in Focal Epilepsies
by: Mehmet Taylan PEKÖZ, et al.
Published: (2021-09-01)

Autoimmune mechanisms in focal epilepsy of unknown cause
by: Elif Sanli, et al.
Published: (2023-01-01)